Egalet
Pharmaceutical company developing proprietary;abuse-deterrent products for the treatment of pain and in other indications
Total raised
€22M
€22,090,908
Funding rounds
2
Investors
3
distinct backers
Active since
2012-04
latest 2013-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood13
base rate 38% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 14y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-09-01 | Growth/Late | €9.1M | Index Ventures | View deal → |
| 2012-05-01 | Series B | €13M | Atlas Venture,Index Ventures,Sunstone Capital | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce